#Memory_Lane | #BIG_PHARMA โ๏ธ ๐ท ๐ ๐ July 15 (Reuters) -
#Pfizer_Inc (PFE.N) has #agreed to #pay $345 million to resolve #claims by consumers who claim they #overpaid for #EpiPens due to #anti_competitive and #unfair_practices by the #drugmaker and the company that markets the #emergency_allergy_treatment, Mylan.
The proposed #class_action settlement was disclosed in a filing in federal court in Kansas City, #Kansas. The deal, which requires a judge's approval, would not resolve claims against Mylan, which is scheduled to face #trial in #January.
Paul Geller, a lawyer for the plaintiffs, said they were "pleased that Pfizer resolved its part of this class action lawsuit over the #pricing of EpiPens."
Pfizer, which did not #admit wrongdoing, did not immediately #respond to a request for comment.
JOBS FOR ALL WORLDWIDE!
CONNECT Today for EARLY #INVITE. TastingTraffic LAUNCHING SOON!
WELCOME TO THE FUTURE OF ADVERTISING! | If it Tastes Good, You Gotta LOVE IT! (Patent Pending).
Upon launch all will be notified.
* Software Architect (PhD) Supervisor -25 years 100K PMS hours
* EXPERT BLACK BOX TESTER
* Founder of SEO (Search Engine Optimization)
* Founder of RTB (Real Time Bidding)
* Founder of HFT (High Frequency Trading)
https://Withbrains.com/@Davidv ยฎ (Decentralized SOCIAL Network | Signup for Early Invite);
https://TastingTraffic.net ยฎ (#International_Tech_News);
http://JustBlameWayne.com ยฎ (Just Blame Wayne & Post it);
http://Davidv.TV ยฎ (Big Faith | Christianity RAW 101) are not affiliates of this provider or referenced images used. This is NOT an endorsement OR Sponsored (Paid) Promotion/Reshare.